Explore our

Strategic AI for single cell sequencing & multi-omics advances

Strategic AI for single cell sequencing & multi-omics advances

Discover how AI is revolutionizing single cell sequencing and multi-omics research. Learn how BioLizard’s Bio|Mx platform blends AI innovation with human expertise to unlock deeper biological insights, accelerate drug discovery, and advance precision medicine.

AI in the life sciences: (Un)limited potential?

AI in the life sciences: (Un)limited potential?

Explore the potential and challenges of AI in drug discovery. BioLizard highlights the importance of high-quality data, human-AI collaboration, and tailored strategies to transform complex biomedical data into actionable insights for more efficient and effective R&D.

Trends in single cell sequencing: Spatial transcriptomics

Trends in single cell sequencing: Spatial transcriptomics

Spatial transcriptomics is emerging as a key trend in single cell sequencing, offering powerful insights into tissue biology and tumor microenvironments. Despite challenges in cost, complexity, and analytics, growing standardization will drive adoption. BioLizard already leads in expert analysis.

Trends in single cell sequencing: Atlases & public data

Trends in single cell sequencing: Atlases & public data

The rise of atlases and public single cell datasets is transforming research by reducing costs, accelerating hypothesis generation, and enriching proprietary data. With expert integration, these resources enable faster target discovery, model selection, and data-driven decisions.

Trends in single cell sequencing: High-throughput technologies

Trends in single cell sequencing: High-throughput technologies

High-throughput single cell sequencing enables millions of cells to be analyzed in parallel at lower cost, boosting large-scale screening, diagnostics, and rare disease research. With expert analytics, it drives robust insights, but strategic planning is essential for success.

The future of multi-omics data analysis

The future of multi-omics data analysis

Multi-omics is shaping the future of biomedicine, fueled by new technologies, machine learning, richer datasets, and clinical integration. As data grows in scale and diversity, AI-powered platforms like BioLizard’s Bio|Mx will drive discovery, precision medicine, and better decision-making.

5 tips for getting the most out of your multi-omics data

5 tips for getting the most out of your multi-omics data

Multi-omics offers deep biological insight, but success depends on smart planning, platform choice, quality control, proper integration, and powerful visualization. With expert guidance and tools like Bio|Mx, your data can fuel discovery and drive impactful decisions.

Multi-omics analysis: Why and when to go beyond single omics?

Multi-omics analysis: Why and when to go beyond single omics?

Multi-omics reveals what single omics can’t: uncovering deeper biological interactions, boosting prediction power, and accelerating discovery. From chronic disease insights to target validation using public data, BioLizard turns complex datasets into actionable breakthroughs.

Spatial transcriptomics and its added value

Spatial transcriptomics and its added value

Spatial transcriptomics bridges the gap between gene expression and tissue context by mapping transcripts to their exact location. By revealing cell interactions, microenvironments, and spatial gene patterns, it provides powerful insights, especially when paired with scRNA-seq.